The 12 closest competitors and alternatives to PolyPeptide Group AG among pharmaceuticals companies — ranked by similarity to what PolyPeptide Group AG actually does, not by market-cap band.
Subscribe to see PolyPeptide Group AG’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Operating globally, PolyPeptide Group AG functions as a prominent contract development and manufacturing organization (CDMO). The company specializes in producing both proprietary and generic GMP-certified peptides, which are supplied to pharmaceutical and biotechnology firms. These crucial components are integrated into approved pharmaceutical products, drugs in various stages of clinical development, and generic medications. PolyPeptide Group also handles the manufacturing of bespoke research-grade peptides and is engaged in the development of neoantigen peptides designed to advance personalized cancer therapies. Its services further encompass the production of peptides for commercially available peptide therapeutics, as well as the creation of peptide-based generics for both human and animal health sectors, alongside peptides for the cosmetics industry. Additionally, the company offers vital regulatory affairs assistance. Established in 1952, PolyPeptide Group AG maintains its corporate headquarters in Zug, Switzerland, and operates as a subsidiary of Draupnir Holding B.V.
PolyPeptide Group AG is a pharmaceuticals company headquartered in Baar, Switzerland. It is publicly listed (0AAJ) with a market capitalisation of $1.8B. Xcout tracks 13 named people at PolyPeptide Group AG, including Juan José Gonzalez (Chief Executive Officer). Xcout recorded 19 job postings from PolyPeptide Group AG in the last 90 days.
7 more named people on record for PolyPeptide Group AG, with roles, board committees and tenure — see the full roster →
Xcout recorded 19 job postings from PolyPeptide Group AG in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see PolyPeptide Group AG's hiring signals →
Ranked by semantic similarity — how close each company is to PolyPeptide Group AG by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Pharma, Life Sciences
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Similar pharmaceuticals company
APPCO Pharma LLC is a U.S.-based pharmaceutical company that provides drug development, manufacturing, and analytical services. It offers formulation development, manufacturing, and analytical validation services for pharmaceutical products, while introducing high-quality and affordable drug products to the market.
Similar pharmaceuticals company
ten23 health is a Switzerland-based pharmaceutical development and manufacturing company focused on complex drug products, including biologics and sterile injectable medicines. It serves biotechnology and pharmaceutical companies by providing formulation, process development, analytical services, and clinical or commercial manufacturing support.
Similar pharmaceuticals company
Supriya Lifescience Limited is a generic pharmaceutical company that develops and manufactures Active Pharmaceutical Ingredients (APIs), finished dosage formulations (FDFs), and therapeutic products. The company serves a global customer base across more than 85 countries, providing pharmaceutical ingredients and contract development and manufacturing (CDMO) services.
Similar pharmaceuticals company
Blue Jet Healthcare Limited manufactures and supplies pharmaceutical intermediates, active pharmaceutical ingredients (APIs), contrast media intermediates, artificial sweeteners, and protected amino acid derivatives. The company serves global pharmaceutical, medical imaging, and FMCG customers through contract development and manufacturing (CDMO) services and proprietary product lines.
Similar pharmaceuticals company
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a Contract Development and Manufacturing Organization (CDMO), offering its services to clients across Mainland China and internationally. The company delivers extensive drug research, development, and manufacturing solutions specifically tailored for pharmaceutical and biotechnology enterprises. Their offerings are comprehensive, covering the entire lifecycle from early clinical stages through to full commercialization, including R&D and cGMP compliant production of advanced intermediates, active pharmaceutical ingredients (APIs), and finished formulations, alongside clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the sale and distribution of medicinal products, and active participation in pharmaceutical science and technology innovation. The company was founded in 1999 and maintains its headquarters in Tianjin, China.
Similar pharmaceuticals company
KD Pharma Group operates as a contract development and manufacturing organization (CDMO) providing services and products for the pharmaceutical and nutraceutical industries. The company specializes in lipids, omega-3s, small molecules, custom synthesis, and finished dosage forms such as softgels and liquids. It serves pharmaceutical companies, nutritional supplement brands, and specialty chemical markets.
Similar pharmaceuticals company
Biotika a.s. is a biotechnology company and manufacturer of active pharmaceutical ingredients, specializing in penicillin and polymyxin B sulfate. The company serves global pharmaceutical markets by providing contract manufacturing, biotechnology scaling services, and research and development.
Pharmaceuticals, Biotechnology & Life Sciences
Mayne Pharma Group Ltd. operates as a specialized pharmaceutical enterprise, dedicated to the global production and distribution of both proprietary (branded) and unbranded (generic) medicinal products. Its extensive market reach spans Australia, New Zealand, North America (the United States and Canada), Europe, and Asia. The company's business activities are organized across four distinct divisions: Metrics Contract Services, International, Branded Products, and Portfolio Products. Mayne Pharma offers innovative oral drug delivery technologies and provides comprehensive contract services, including pharmaceutical development, manufacturing, and analytical support to external clients. Furthermore, the firm specializes in the distribution of pharmaceutical products tailored for key therapeutic areas such as dermatology, women's health, and infectious diseases. Incorporated in 2005, and headquartered in Salisbury South, Australia, the company was formerly known as Halcygen Pharmaceuticals Limited before rebranding to Mayne Pharma Group Limited in November 2010.
Similar pharmaceuticals company
Aenova Group is a leading worldwide contract manufacturer for the pharmaceutical and healthcare industry, headquartered in Starnberg, Germany. The company provides comprehensive development, manufacturing, and technology services for pharmaceutical products.
Similar pharmaceuticals company
Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.
Similar pharmaceuticals company
Daito Pharmaceutical Co.,Ltd. is a global entity primarily involved in the creation and sale of a diverse range of pharmaceutical products. Their offerings span active pharmaceutical ingredients (APIs) and chemical intermediates, alongside both prescription and over-the-counter (OTC) medications, and home-delivered medicines. These products are available in various formats, including tablets, capsules, lozenges, granules, and powdered forms. Beyond its own brand, the company also provides contract manufacturing services, developing medicinal formulations for other pharmaceutical firms. Additionally, Daito Pharmaceutical markets health food products. Established in 1942, it was initially known as Daito Corporation, changing to its current name in 1992, and maintains its headquarters in Toyama, Japan.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for PolyPeptide Group AGand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →